Presentation TCT 2017 PFO Closure for Hypoxemia: Who Responds and Who Does Not? Designing a Trial to Prove the Concept Presenter: Mark Reisman, Brian K. Whisenant, Joseph Kay November 01, 2017
Presentation TCT 2017 PFO Closure for Migraine: Dead, Alive, or in Need of Another Trial? Presenter: Mark Reisman, Brian K. Whisenant, Robert J. Sommer November 01, 2017
Presentation TCT 2017 VTE and PFO Closure: Device? Anticoagulation? Both? Presenter: Mark Reisman, Brian K. Whisenant, Christian Spies November 01, 2017
Presentation TCT 2017 Complications During and After PFO Closure, Case #3: Arrhythmias Presenter: John F. Rhodes, Robert J. Sommer November 01, 2017
Presentation TCT 2017 Complications During and After PFO Closure, Case #2: Chest Pain Presenter: John F. Rhodes, Robert J. Sommer, Clifford J. Kavinsky November 01, 2017
Presentation TCT 2017 Complications During and After PFO Closure, Case #1: Pericardial Effusion Presenter: John F. Rhodes, Robert J. Sommer, Igor F. Palacios November 01, 2017
Presentation TCT 2017 Case #3: IVC Filter/Obstructed IVC Presenter: John F. Rhodes, Robert J. Sommer, Anita Asgar November 01, 2017
Presentation TCT 2017 Challenging Anatomies, Case #2: The 20mm PFO and Atrial Septal Aneurysm Presenter: John F. Rhodes, Robert J. Sommer, Thomas M. Tu November 01, 2017
Presentation TCT 2017 Challenging Anatomies, Case #1: The Long Rigid Tunnel Presenter: John F. Rhodes, Robert J. Sommer, Eustaquio Maria Onorato November 01, 2017
Presentation TCT 2017 Device Sizing for the Amplatzer PFO Occluder: Forget the IFU Presenter: John F. Rhodes, Robert J. Sommer, Richard Smalling November 01, 2017
Presentation TCT 2017 Review of PFO Closure Devices, and an Anatomy-specific Approach to Device Selection Presenter: John F. Rhodes, Robert J. Sommer, Mark Reisman November 01, 2017
Presentation TCT 2017 Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? No! Presenter: Lee N. Benson, Megan Coylewright, David E. Thaler November 01, 2017
Presentation TCT 2017 Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? Yes! Presenter: Lee N. Benson, Megan Coylewright, Guillaume Turc November 01, 2017
Presentation TCT 2017 Shared Decision-making for PFO Closure: How to Make the FDA Requirements Work Presenter: Lee N. Benson, Megan Coylewright November 01, 2017
Presentation TCT 2017 The PFO Clinic: Neurologists and Cardiologists as a Team Presenter: Lee N. Benson, Megan Coylewright, Lars Sondergaard November 01, 2017
Presentation TCT 2017 Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage III - FDA Perspective Presenter: Robert J. Sommer, David L. Tirschwell, Andrew Farb November 01, 2017
Presentation TCT 2017 Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage II - Patient Advocates Perspective Presenter: Robert J. Sommer, David L. Tirschwell, Bray Patrick-Lake November 01, 2017
Presentation TCT 2017 Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage II - Cardiology Perspective Presenter: Robert J. Sommer, David L. Tirschwell, John D. Carroll November 01, 2017
Presentation TCT 2017 Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage I - Neurology Perspective Presenter: Robert J. Sommer, David L. Tirschwell November 01, 2017
Presentation TCT 2017 Pivotal PFO Stroke Trial Update I: REDUCE Presenter: Robert J. Sommer, David L. Tirschwell, John F. Rhodes November 01, 2017